Optimal biological dose: a systematic review in cancer phase I clinical trials

by J. Fraisse, D. Dinart, D. Tosi, C. Bellera, C. Mollevi
Published 2021-01-01

GUIP1: a R package for dose escalation strategies in phase I cancer clinical trials

by D. Dinart, J. Fraisse, D. Tosi, A. Mauguen, C. Touraine, S. Gourgou, M. C. Le Deley, C. Bellera, C. Mollevi
Published 2020-06-01

Radiofrequency ablation of stage IA non–small cell lung cancer in patients ineligible for surgery: results of a prospective multicenter phase II trial

by J. Palussière, F. Chomy, M. Savina, F. Deschamps, J. Y. Gaubert, A. Renault, O. Bonnefoy, F. Laurent, C. Meunier, C. Bellera, S. Mathoulin-Pelissier, T. de Baere
Published 2018-08-01